Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ AC Immune rises after amending licensing deal with Lilly (SeekingAlpha) +++ AC IMMUNE Aktie -4,40%

PEIJIA MEDICAL Aktie

 >PEIJIA MEDICAL Aktienkurs 
0.683 EUR    (TradegateBSX)
Ask: 0.71 EUR / 7043 Stück
Bid: 0.655 EUR / 7634 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
PEIJIA MED Aktie über LYNX handeln
>PEIJIA MEDICAL Performance
1 Woche: +1,1%
1 Monat: +5,4%
3 Monate: -5,2%
6 Monate: -5,2%
1 Jahr: +15,2%
laufendes Jahr: -2,2%
>PEIJIA MEDICAL Aktie
Name:  PEIJIA MEDICAL HD -,01
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG6981F1090 / A2P4JC
Symbol/ Ticker:  4WO (Frankfurt)
Kürzel:  FRA:4WO, ETR:4WO, 4WO:GR
Index:  -
Webseite:  http://www.peijiamedical...
Profil:  Peijia Medical Ltd. specializes in the development, manufacturing, and commercialization of high-quality medical devices. Focused primarily on innovative solutions for the treatment of cardiovascular and neurovascular diseases, the company plays a cr..
>Volltext..
Marktkapitalisierung:  456.55 Mio. EUR
Unternehmenswert:  436.54 Mio. EUR
Umsatz:  86.41 Mio. EUR
EBITDA:  -17.48 Mio. EUR
Nettogewinn:  -24.61 Mio. EUR
Gewinn je Aktie:  -0.04 EUR
Schulden:  53.8 Mio. EUR
Liquide Mittel:  72.73 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.9
Umsatzwachstum:  16.35%
Gewinnwachstum:  10.01%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  PEIJIA MEDICAL, PEIJIA MED
Letzte Datenerhebung:  07.04.26
>PEIJIA MED Kennzahlen
Aktien/ Unternehmen:
Aktien: 669.28 Mio. St.
Frei handelbar: 63.93%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 1022
Umsatz/Mitarb.: 0.08 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 53.93%
Bewertung:
KGV: -
KGV lG: 179.8
KUV: -
KBV: -
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 66.74%
Gewinnmarge: -28.48%
Operative Marge: -29.7%
Managementeffizenz:
Gesamtkaprendite: -7.6%
Eigenkaprendite: -10.5%
>PEIJIA MED Peer Group
Gesundheit, Herz-Kreislauf- Behandlung/ Kardiologie, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
26.03.26 - 01:45
On Move: Peijia Medical CEO Plans to Spend Up to HKD15 Million to Increase Shareholding (AAStocks)
 
Peijia Medical-B (09996.HK) announced that its CEO, Zhang Yi, through a company he controls, plans to continue purchasing company shares on the open market starting today (26th). The total expected cost of this shareholding increase is not to exceed HKD15 million. (ca/da)~AASTOCKS Financial NewsWebsite: www.aastocks.com...
25.03.26 - 19:30
Results: Peijia Medical Narrows Full-Year Loss to RMB203 Million (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
23.02.26 - 09:51
XFRA: MWBMU - HANDELSUNTERBRECHUNG - TEIL 2 (XETRA)
 
AU000000GMD9 SG1M49904634 CA23344H1091 NZMLNE0001S0 KYG2S85A1045 AU0000066508 US58844R8842 KYG549581067 GB00BJL1ZF49 HK0000504214 GB00BPJHZ015 GB00BYYJL418 GB00BLH32M40 MHY622674098 JP3868500004 CA7469601032 GB00BN33TR63 AU0000119307 CA1358711010 KYG9898S1075 CA92834E3068 US69346N1072 SG1W55939399 KYG9898C1024 CA82938H1073 JP3601800000 SE0015949946 PLCLDTC00019 CA74739G1072 CNE1000076P8 US39813G1094 AU000000ALI3 JP3292900002 BMG2233G2014 PLGRMID00019 AU0000122251 GB00BMYX7295 BMG6682J1036 US6915436074 PLSTRWI00019 CA87402A1084 JP3759800000 KYG5340S1093 CA76611L2030 PLBKDGM00019 SE0010245373 HK0000544194 PLGNMTC00017 US4404071049 KYG6981F1090 AU0000079212 KYG2929M1087 SG1CI9000006 US29445S1006 KYG4066M1151 VGG0542G1028 SE0026820854 KYG009701064 US03464Y1082 US98955N2071 SG1EB6000000 US20451Q1040 NO0013711739 GB00BMDXQ672 US54572F1012 CA94357L1058 GB00BTXYPJ53 CNE1000040M1 CNE1000031F4 IT0005453003 SE0015988274 PLCRTCH00017 US09549B1044...
09.02.26 - 07:45
Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System (PR Newswire)
 
HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developed GeminiOne Transcatheter Edge-to-Edge Repair (TEER)......
12.12.25 - 13:36
Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System, Pioneering Treatment for Aortic Regurgitation in China (PR Newswire)
 
HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its TaurusTrio Transcatheter Aortic Valve (TAV) system received approval from......
25.08.25 - 18:48
Peijia Medical reports results for the six months ended June 30 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.25 - 14:06
Peijia Medical Announces 2025 Interim Results (PR Newswire)
 
HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months ended June 30, 2025 ("the Reporting Period") on......
01.04.25 - 14:01
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products (PR Newswire)
 
SUZHOU, China, April 1, 2025 /PRNewswire/ -- Today, April 1st, Peijia Medical Technology (Suzhou) Co., Ltd. held a strategic innovation cooperation signing ceremony and a press conference to announce the research and development achievements of polymer heart valves using ultra-high......
26.03.25 - 13:03
Peijia Medical Announces 2024 Annual Results (PR Newswire)
 
HONG KONG, March 26, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the year ended December 31, 2024 ("the Year") on March 25,......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Unsere Gesellschaft hat viel mehr Vertrauen in Dinge, die sich nicht ändern. - Univ.-Prof. Mag. Dr. Markus Hengstschläger
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!